{"entity":{"type":"insider","cik":"0001623609","url":"/insider/0001623609","json_url":"/insider/0001623609.json","name":"Lee Tom Y","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":11,"first":"2016-12-22","last":"2022-12-19","span_basis":"filed_date"},"name_variants":[{"name":"Lee Tom Y","source":"filing","n_filings":11,"first_seen":"2016-12-22","last_seen":"2022-12-19"}],"transactions":[{"id":6279295,"accession":"0001209191-22-062029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062029","line_url":"/filing/0001209191-22-062029#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.131,"price_display":"0.13","price_state":"stated","total_value":6550.0,"total_display":"6,550.00","shares_owned_after":5001843.0,"shares_owned_after_display":"5,001,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6250554,"accession":"0001209191-22-020677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-020677","line_url":"/filing/0001209191-22-020677#line-3","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":185000.0,"shares_display":"185,000","price_per_share":0.198,"price_display":"0.20","price_state":"stated","total_value":36630.0,"total_display":"36,630.00","shares_owned_after":4951843.0,"shares_owned_after_display":"4,951,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-22","scope":"insider"},{"id":6250551,"accession":"0001209191-22-020677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-020677","line_url":"/filing/0001209191-22-020677#line-2","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13250.0,"shares_display":"13,250","price_per_share":0.179,"price_display":"0.18","price_state":"stated","total_value":2371.75,"total_display":"2,371.75","shares_owned_after":4766843.0,"shares_owned_after_display":"4,766,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-22","scope":"insider"},{"id":6250550,"accession":"0001209191-22-020677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020677","line_url":"/filing/0001209191-22-020677#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer), Ten percent owner","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21227.0,"shares_display":"21,227","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":3820.86,"total_display":"3,820.86","shares_owned_after":4753593.0,"shares_owned_after_display":"4,753,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-22","scope":"insider"},{"id":4622198,"accession":"0001209191-21-042593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-042593","line_url":"/filing/0001209191-21-042593#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35998.0,"shares_display":"35,998","price_per_share":0.431,"price_display":"0.43","price_state":"stated","total_value":15515.138,"total_display":"15,515.14","shares_owned_after":4732366.0,"shares_owned_after_display":"4,732,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-22","scope":"insider"},{"id":2660281,"accession":"0001209191-20-065235","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-065235","line_url":"/filing/0001209191-20-065235#line-5","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":851.0,"shares_display":"851","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":553.15,"total_display":"553.15","shares_owned_after":4696368.0,"shares_owned_after_display":"4,696,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-24","filed_date":"2020-12-28","scope":"insider"},{"id":2660277,"accession":"0001209191-20-065235","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-065235","line_url":"/filing/0001209191-20-065235#line-4","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45299.0,"shares_display":"45,299","price_per_share":0.662,"price_display":"0.66","price_state":"stated","total_value":29987.938,"total_display":"29,987.94","shares_owned_after":4695517.0,"shares_owned_after_display":"4,695,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider"},{"id":2660272,"accession":"0001209191-20-065235","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-065235","line_url":"/filing/0001209191-20-065235#line-3","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7859.0,"shares_display":"7,859","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":5344.12,"total_display":"5,344.12","shares_owned_after":4650218.0,"shares_owned_after_display":"4,650,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-28","scope":"insider"},{"id":2660267,"accession":"0001209191-20-065235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065235","line_url":"/filing/0001209191-20-065235#line-2","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4712.0,"shares_display":"4,712","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":3062.8,"total_display":"3,062.80","shares_owned_after":4642359.0,"shares_owned_after_display":"4,642,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-28","scope":"insider"},{"id":2660260,"accession":"0001209191-20-065235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065235","line_url":"/filing/0001209191-20-065235#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.665,"price_display":"0.66","price_state":"stated","total_value":13300.0,"total_display":"13,300.00","shares_owned_after":4637647.0,"shares_owned_after_display":"4,637,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-28","scope":"insider"},{"id":2510582,"accession":"0001209191-20-038334","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-038334","line_url":"/filing/0001209191-20-038334#line-3","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13124.0,"shares_display":"13,124","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":22573.28,"total_display":"22,573.28","shares_owned_after":4617647.0,"shares_owned_after_display":"4,617,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-22","scope":"insider"},{"id":2510576,"accession":"0001209191-20-038334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038334","line_url":"/filing/0001209191-20-038334#line-2","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":18500.0,"total_display":"18,500.00","shares_owned_after":4604523.0,"shares_owned_after_display":"4,604,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-22","scope":"insider"},{"id":2510570,"accession":"0001209191-20-038334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038334","line_url":"/filing/0001209191-20-038334#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.7499,"price_display":"1.75","price_state":"stated","total_value":52497.0,"total_display":"52,497.00","shares_owned_after":4594523.0,"shares_owned_after_display":"4,594,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider"},{"id":3278503,"accession":"0001209191-20-037706","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037706","line_url":"/filing/0001209191-20-037706#line-4","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26876.0,"shares_display":"26,876","price_per_share":1.605,"price_display":"1.60","price_state":"stated","total_value":43135.98,"total_display":"43,135.98","shares_owned_after":4564523.0,"shares_owned_after_display":"4,564,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-18","scope":"insider"},{"id":3278497,"accession":"0001209191-20-037706","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-037706","line_url":"/filing/0001209191-20-037706#line-3","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":1.619,"price_display":"1.62","price_state":"stated","total_value":113330.0,"total_display":"113,330.00","shares_owned_after":4537647.0,"shares_owned_after_display":"4,537,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"},{"id":3278493,"accession":"0001209191-20-037706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037706","line_url":"/filing/0001209191-20-037706#line-2","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":109200.0,"total_display":"109,200.00","shares_owned_after":4467647.0,"shares_owned_after_display":"4,467,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-18","scope":"insider"},{"id":3278484,"accession":"0001209191-20-037706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-037706","line_url":"/filing/0001209191-20-037706#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45157.0,"shares_display":"45,157","price_per_share":1.909,"price_display":"1.91","price_state":"stated","total_value":86204.713,"total_display":"86,204.71","shares_owned_after":4407647.0,"shares_owned_after_display":"4,407,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-18","scope":"insider"},{"id":3253859,"accession":"0001209191-20-008081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008081","line_url":"/filing/0001209191-20-008081#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":754884.0,"shares_display":"754,884","price_per_share":0.289,"price_display":"0.29","price_state":"stated","total_value":218161.476,"total_display":"218,161.48","shares_owned_after":22891070.0,"shares_owned_after_display":"22,891,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2020-02-10","scope":"insider"},{"id":8677495,"accession":"0001209191-19-052410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-052410","line_url":"/filing/0001209191-19-052410#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":290000.0,"total_display":"290,000.00","shares_owned_after":22136186.0,"shares_owned_after_display":"22,136,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-02","filed_date":"2019-10-03","scope":"insider"},{"id":6608370,"accession":"0001209191-18-047688","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047688","line_url":"/filing/0001209191-18-047688#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2336187.0,"shares_display":"2,336,187","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":1051284.15,"total_display":"1,051,284.15","shares_owned_after":21002853.0,"shares_owned_after_display":"21,002,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-20","scope":"insider"},{"id":5256138,"accession":"0001209191-17-067662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-067662","line_url":"/filing/0001209191-17-067662#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18666666.0,"shares_display":"18,666,666","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":18666666.0,"shares_owned_after_display":"18,666,666","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2017-12-29","scope":"insider"},{"id":3218885,"accession":"0001209191-16-156591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156591","line_url":"/filing/0001209191-16-156591#line-1","is_derivative":false,"issuer_cik":"0001006028","issuer_name":"PURE BIOSCIENCE, INC.","issuer_ticker":"PURE","issuer_name_source":null,"issuer_url":"/issuer/0001006028","owner_cik":"0001623609","owner_name":"Lee Tom Y","owner_url":"/insider/0001623609","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14885.0,"shares_display":"14,885","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":14140.75,"total_display":"14,140.75","shares_owned_after":3684452.0,"shares_owned_after_display":"3,684,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-21","filed_date":"2016-12-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001006028","name":"PURE BIOSCIENCE, INC.","url":"/issuer/0001006028","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":11,"first_seen":"2016-12-22","last_seen":"2022-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001623609","retrieved_at":"2026-08-21T22:50:01+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}